Date & Time of Session - 3/6/26 - from 12:00 - 1:00PM

Overview
Acute Coronary Syndromes (ACS) is an ischemic condition with acute and chronic sequelae. Current therapy relies on reperfusion of the occluded vessel, followed by secondary preventative strategies to minimize further complications and recurrent events. Current ACS guidelines recommend beta-blockers in all ACS patients, however, most supporting literature predates reperfusion strategies. Additionally, literature surrounding newer non-statin lipid lowering therapy demonstrates additional cardiovascular risk reduction with lower low-density lipoprotein (LDL) targets. This presentation will investigate if beta-blockers continue to provide significant benefit in this contemporary era following an ACS event, and if there is additional benefit in targeting lower LDL goals than what is currently recommended

Objectives
Upon completion of this activity, participants will be able to:
1. Review current guideline recommendations on beta-blocker therapy and lipid management within Acute Coronary Syndromes (ACS)
2. Evaluate historical and current evidence surrounding use of beta blockers in post-ACS patients
3. Analyze efficacy and safety outcomes of recent trials investigating non-statin low-density lipoprotein (LDL)-lowering therapy
4. Apply evidence-based knowledge within clinical scenarios to improve patient outcomes

    Target Audience
    Pharmacists, residents, and students

    Special Services
    If you require special assistance to attend this event, please call Megan Russell at (304) 550-0896.

    Speaker:
    Andre Anderson, PharmD
    PGY1 Acute Care Pharmacy Resident
    UK College of Pharmacy - Lexington, Kentucky

    Session date: 
    03/06/2026 - 12:00pm EST to 05/04/2026 - 11:59pm EDT
    Add to calendar: 
    • 1.00 ACPE

      In support of improving patient care, UK HealthCare CECentral is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), the American Nurses Credentialing Center (ANCC), and the Association of Social Work Boards (ASWB) to provide continuing education for the healthcare team.

      This knowledge-based activity will award 1.00 contact hour(s) (0.100 CEUs) of continuing pharmacy education credit in states that recognize ACPE providers. Course JA-UAN Number: JA0000312-0000-25-046-L01-P

    • 1.00 Participation
      UK Healthcare CECentral certifies this activity for 1.00 hour(s) of participation.
    Please login or register to take this course.
    Faculty List: 
    Speaker(s)

    Andre Anderson, PharmD

    has no relevant financial relationships to disclose at this time.